Structured Summary
Abstract
Antibodies, often monoclonal, in which the two antigen-binding sites are specific for separate ANTIGENIC DETERMINANTS. They are artificial antibodies produced by chemical crosslinking, fusion of HYBRIDOMA cells, or by molecular genetic techniques. They function as the main mediators of targeted cellular cytotoxicity and have been shown to be efficient in the targeting of drugs, toxins, radiolabeled haptens, and effector cells to diseased tissue, primarily tumors.
MeSH Record
Classification
Broader headings
Related Concepts
Knowledge Graph
Drag nodes to rearrange; hover to trace links; click a node to open its page.
Drug Class
Pharmacological Action
MeSH Record
See Also
MeSH Record
Synonyms
6 entry terms
- Antibodies, Bispecific
- Bifunctional Antibodies
- Antibodies, Bifunctional
- Bispecific Monoclonal Antibodies
- Antibodies, Bispecific Monoclonal
- Monoclonal Antibodies, Bispecific
MeSH Record
Aspects Covered
24 allowable subheadings
Indexed with the subheadings administration & dosage, adverse effects, analysis, biosynthesis, blood, cerebrospinal fluid, chemistry, classification, drug effects, economics, genetics, history, immunology, isolation & purification, metabolism, pharmacokinetics, pharmacology, physiology, poisoning, radiation effects, therapeutic use, toxicity, ultrastructure, urine.
MeSH Record
Indexing Annotation
do not coordinate with ANTIBODY FORMATION for /biosynthesis
MeSH Record
History Note
94
MeSH Record
Previous Indexing
- Antibodies (1985-1993)
- specific Antibodies (1985-1993)
MeSH Hierarchy
Tree Numbers
AMA Style
References
- National Library of Medicine. Bispecific Antibodies. Medical Subject Headings (MeSH). 2026. Unique ID D018033. http://id.nlm.nih.gov/mesh/2026/D018033
- Bispecific Antibodies. In: Wikidata. https://www.wikidata.org/wiki/Q76120612